Cox, Cleveland Clinic form alliance for innovative home health

Cox Communications and Cleveland Clinic have formed Vivre Health, a strategic alliance focused on innovative telehealth and home health solutions.

"We are thrilled to be working with such a respected leader in the healthcare space," said Asheesh Saksena, executive vice president and chief strategy officer, Cox Communications, in a release.  "Fueled by access to broadband, we believe the home will be an increasingly important node within the healthcare delivery architecture and Vivre Health is uniquely positioned to help drive this transformation." 

Leading its peers and competitors in the industry, Cox recently committed to deliver residential Gigabit Internet speeds to all markets it serves by the end of 2016.

"Healthcare transformation will be led by organizations that embrace innovation and collaboration," said Thomas Graham, MD, chief innovation officer, Cleveland Clinic. "This alliance will accelerate the creation, development and delivery of solutions that will improve and extend human life."

Cox Communications also has invested in HealthSpot, a pioneer in patient and provider driven telehealth technology. HealthSpot has built a comprehensive healthcare delivery platform that combines cloud-based software with their award-winning HealthSpot station, digital medical devices and mobile applications. This solution is being piloted across several states by leading healthcare, pharmacy and retail services providers.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.